Frontiers
US$ 28.39
abbvie glp-1 receptor agonist weight management diabetes treatments Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Contemporary Management of Obesity: A
Description
These medications offer a promising approach to weight management and blood sugar control
Enhanced endosomal signaling and desensitization of GLP-1R vs GIPR in pancreatic Beta cells
K(ATP) channels and islet hormone secretion: new insights and controversies
At the end of the trial, mean weight loss of 4.4% is reported in the combination group, compared to 1.6% for placebo
Understanding your treatment options is essential, especially as new, effective medications like Zepbound , Wegovy, and Ozempic become available
